Private Ocean’s Ligand Pharmaceuticals LGND Stock Holding History

Private Ocean’s Portfolio LGND Stock Details LGND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-5	Closed	–	–	598
2022 Q2	$0	Hold	5	–	–	﹤0.01%	574
2022 Q1	$0	Buy	+5	New	+$363	﹤0.01%	665
2021 Q3	–	Sell	-42	Closed	-$3K	–	604
2021 Q2	$3K	Hold	42	–	–	﹤0.01%	477
2021 Q1	$4K	Buy	+42	New	+$3.97K	﹤0.01%	510
2020 Q4	–	Sell	-42	Closed	-$2K	–	525
2020 Q3	$2K	Hold	42	–	–	﹤0.01%	478
2020 Q2	$2K	Sell	42 -35	-45%	-$2.22K	﹤0.01%	444
2020 Q1	$3K	Buy	+77	New	+$4.36K	﹤0.01%	464

Other funds holding LGND

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

SDJVC

St. Denis J. Villere & Co New Orleans, Louisiana $907M AUM 10.61% 1-Year Est. Return

Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return

SIMG

Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

Private Ocean's LGND Position: Q3 2022 in Review

Private Ocean sold out of Ligand Pharmaceuticals (LGND) in Q3 2022, closing a stake of 5 shares.

Private Ocean first reported a position in LGND in Q1 2020 and held it in 7 quarters. The position peaked at $4K in Q1 2021. 205 funds tracked by Wall St. Rank hold LGND as of Q3 2022.

Private Ocean reported no remaining Ligand Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
Private Ocean sold 5 Ligand Pharmaceuticals shares in Q3 2022.
Private Ocean first reported a position in Ligand Pharmaceuticals in Q1 2020 and held it in 7 quarters.
Private Ocean's Ligand Pharmaceuticals position peaked at $4K in Q1 2021.
205 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q3 2022.

Based on Private Ocean's 13F filing for Q3 2022, filed 24 Oct 2022.